Drug Database
Back to search

Switzerland· 65052003

Janumet XR 100 mg/1000 mg, Filmtabletten

A metformin and sitagliptin product, registered in Switzerland by MSD Merck Sharp & Dohme AG and dispensed under Swissmedic category B. The same ATC class is registered in 14 of our 19 countries.

Cat B (Swissmedic)ATC A10BD07

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedJanumet XR 100 mg/1000 mg, Filmtablet…ATCA10BD07REGISTER NO.65052003PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about JanumetAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and sitagliptin is registered in 14 of 19 countries.

Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.

  • This record: Switzerland
  • 9 of them publish a price we can compare per daily dose
Search metformin and sitagliptin products by name

Metformin and sitagliptin · ATC A10BD07

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
MSD Merck Sharp & Dohme AG
Country
Switzerland (CH)
ATC code
A10BD07
ATC class
Metformin and sitagliptin
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and sitagliptin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and sitagliptin against other medicinesHow interaction checks work

Metformin and sitagliptin · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under A10BD07

Metformin and sitagliptin, as other registers publish it.

All metformin and sitagliptin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd3ac5af-b625-4e4a-afb0-bdce33c41f09
GET /v1/drugs/fd3ac5af-b625-4e4a-afb0-bdce33c41f09?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about metformin and sitagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console